Page 76 - Read Online
P. 76

the TdT-mediated dUTP nick end labeling (TUNEL) assay.    as mean ± standard error. Values with P > 0.05 are not
                                                         [17]
          The TUNEL assay was performed using a kit (in situ cell death   significantly different while values with P < 0.05 and P < 0.01
          detection kit, Roche Molecular Biochemicals, Manheim,   are significantly and highly significantly different respectively.
          Germany) according to the protocol provided by the   F-probability expresses the general effect between groups.
          manufacturer, while Bcl-2 and p53 reactivity were determined
          following method of Gao and Zhou.  Briefly, before the   RESULTS
                                         [18]
          incubation with antibodies, endogenous peroxidase activity
          was quenched, slides washed and then incubated in a   Effects on animal survival and mortality
          blocking solution of hydrogen peroxide 1% in methanol, in   After 2 weeks of EAC-intraperitoneal transplantation, 8 of
          darkness for 15 min. Antigen retrieval occurred in citrate   12 mice administered 10% DMSO as a vehicle survived; the
          buffer 10 mmol/L, pH = 6.0. After cooling, sections were   survival percentage was 66.66%. The treatment of EAC-bearing
          rinsed in tap water and then phosphate buffer saline (PBS).   mice with DADS markedly increased the survival percentage
          Primary antibodies for either Bcl-2 (DakoCytomation, USA)   to reach 83.33% at the end of the experiment [Table 1].
          or p53 (Lab Vision Corporation, 47777 Warm Springs Blvd,
          Fremont, CA, USA), diluted 1:150 and 1:100, respectively in   Effects on EAC-fl uid volume and cell number in vivo
          PBS, were applied for 1 h at 37 °C. Secondary biotinylated   The inhibitory effect of DADS on EAC-cells in vivo was tested
          antibody diluted 1:100 and 1:200 in PBS was applied for a   in terms of EAC-fluid volume, number of total and alive
          period of 30 min at 37 °C. Streptavidin-biotin or avidin-biotin   EAC-cells, and number and percent of EAC-dead cells. The
          complex with horseradish peroxidase (ABC/HRP) was applied   daily treatment of EAC-bearing mice with DADS for 2 weeks
          for 10 min at room temperature. Bound antibody complex   after EAC-cells intraperitoneal transplantation induced a
          was visualized by the reaction of 3, 3’-diaminobenzidine (DAB)   significant decrease (LSD; P < 0.05) of EAC-fluid volume,
          substrate and counterstained with hematoxylin. Secondary   number of total and alive EAC-cells. On the other hand, the
          biotinylated antibody, ABC/HRP and DAB were obtained from   number and percent of dead EAC-cells exhibited a potential
          Zymed Laboratories (Invitrogen Immunoprotection, 561   increase (LSD; P  < 0.01) as compared to EAC-bearing
          Eccles Avenue, South San Francisco, CA, USA). Hematoxylin   control counterparts. The ratio of EAC-fluid volume to total
          was obtained from Sigma Chemical Company, USA.      EAC-number was also highly significantly (LSD; P < 0.01)
                                                              increased in EAC-bearing mice treated with DADS as
          Imaging and semi-quantitative analysis of Bcl-2, p53 and   compared with control mice [Table 1].
          terminal deoxynucleotidyl transferase
          The yellowish brown colored stained area were analyzed   With regards to one-way ANOVA, it was found that the
          in pixels; percent area and intensity were detected   effect between groups on number of total and alive
          by ImageJ software, US National Institutes of Health,   EAC-cells and percent of dead cells was very highly
          Bethesda, Maryland, USA (http://imagej.nih.gov/ij/).  significant (F-probability; P < 0.001), while the effect on
                                                              EAC-volume and number of dead cells was only highly
          Anti-tumor cytotoxicity against EAC-cells in vitro  significant (P < 0.01) [Table 1].
          The viability of cells as a result of 6 different concentrations
          (0, 6.25, 12.5, 25, 50, and 100 μg/mL) of DADS was tested   Effect on plasma and ascites sialic acid level in vivo
          by trypan blue exclusion assay according to the method of   Plasma sialic acid level in EAC-bearing mice was highly
          Ahmed and Ahmed.  Briefly, EAC-cells at concentration   significantly (P < 0.01; -35.05%) decreased as a result of
                           [19]
          2.5 × 10  cells/mL suspended in PBS were incubated at 37 °C   treatment with DADS. The ascites sialic acid concentration
                 5
          for 2 h in the presence of different concentrations of DADS   was also highly significantly (P < 0.01; -28.49%) decreased
          dissolved in dimethyl sulfoxide. At the end of incubation   in EAC-bearing mice treated with DADS as compared with
          period, equal volume of trypan blue solution was added to   EAC-bearing control [Table 2].
          sample cells, then the stained cells (dead cells) and unstained
          cells (alive cells) were counted using Neubauer hemocytometer.   Histological and immunohistochemical effects on EAC-cells
          The percent of dead cells for each test was calculated.  As indicated by low and high magnification, EAC cells of
                                                              EAC-bearing control female mice [Figure 1a and c] were
          Statistical analysis                                characterized with abundant basophilic and dark stained
          Data were analyzed by one-way analysis of variance (ANOVA)   cytoplasm as well as moderate sized nuclei. As a result of
          followed by a least significance difference (LSD) test to   treatment with DADS [Figure 1b and d], EAC-cells decreased
          compare the groups with each other.  Data were expressed   in number and size and appeared with a narrow rim of
                                        [20]



               Hepatoma Research | Volume 1 | Issue 2 | July 15, 2015                                        69
   71   72   73   74   75   76   77   78   79   80   81